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Introduction 
Tufted angioma is a rare, benign vascular tumor of 
uncertain pathogenesis, characterized 
histopathologically by “tufts” of capillaries within the 
dermis [1]. These tumors typically occur during 
infancy or early childhood, with approximately half 
present at birth and the majority of the rest 
presenting within the first year of life. 
Case Synopsis 
A 10-month-old boy presented for evaluation of an 
erythematous patch of his medial right upper 
extremity. The patch appeared rapidly at 
approximately 5 months of age and had not changed 
significantly since appearance. The patient’s parents 
reported no symptoms. Prior to referral to the 
dermatology clinic, the patient’s pediatrician had 
treated him with topical mupirocin and topical 
hydrocortisone 2.5% cream without improvement. 
On presentation, the patient had an annular and 
reticulated erythematous patch of the right medial 
upper extremity without surface change (Figure 1). 
Abstract 
Tufted angioma is a rare, benign vascular tumor of 
uncertain pathogenesis, characterized 
histopathologically by “tufts” of capillaries within the 
dermis. A life-threatening coagulopathy, Kasabach-
Merritt phenomenon, occurs in approximately 10% of 
cases of tufted angioma and is characterized by 
profound thrombocytopenia and fibrinogen 
consumption. We present an asymptomatic 10-month-
old boy who presented with an erythematous patch of 
the right upper extremity and subsequently was 
diagnosed by biopsy with tufted angioma. Baseline 
laboratory workup of our patient revealed mildly 
decreased fibrinogen and elevated D-dimer levels 
without thrombocytopenia or elevated partial 
thromboplastin time. This suggests that asymptomatic 
patients with tufted angioma may present with 
coagulopathy in the absence of Kasabach-Merritt 
phenomenon. This also highlights the importance of 
obtaining baseline laboratory workup in patients 
presenting with tufted angioma. 
 
Figure 1. Reticulated erythematous patch of the right upper 
extremity. 
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A 3mm punch biopsy was performed. Pathology 
showed a vascular proliferation in the superficial 
dermis with spindled and polygonal cells (Figure 2). 
The vascular nature of the lesion was confirmed with 
positive CD31 and ERG immunohistochemical stains. 
A diagnosis of tufted angioma was made. 
Laboratory workup for our patient included a mildly 
elevated partial thromboplastin time at 32 seconds 
(reference range (RR): <30 seconds), mildly 
decreased fibrinogen 141mg/dL (RR: 180-
363mg/dL), and elevated D-dimer at 1960ng/mL (RR: 
190-500ng/mL). Complete blood count, including 
platelets, comprehensive metabolic panel, and 
prothrombin time were within normal limits. 
 
Case Discussion 
Tufted angiomas are rare and the precise incidence 
is unknown. It is closely associated with kaposiform 
hemangioendothelioma, a more aggressive tumor, 
with the processes believed to be part of a 
continuum [2]. 
A life-threatening coagulopathy, Kasabach-Merritt 
phenomenon occurs in approximately 10% of cases 
of tufted angioma and 70% of cases of kaposiform 
hemangioendothelioma [3]. In these cases 
prominent thrombocytopenia and consumption of 
fibrinogen and coagulation factors can be seen, with 
tumors becoming tense, painful, and purpuric. This 
phenomenon is believed to be result of platelet 
trapping within the tumor vasculature. Infantile 
hemangiomas, the most common vascular tumors of 
infancy, are not associated with Kasabach-Merritt 
phenomenon [4]. 
Surgical excision is the definitive treatment for small 
or localized tufted angiomas [5]. Observation is an 
option in asymptomatic cases and there have been 
cases of spontaneous regression [6]. For 
symptomatic, nonresectable cases low-dose aspirin 
may have a benefit [4, 7]. Although our patient has 
mild laboratory abnormalities, given the lesion is 
asymptomatic and stable, we elected for close 
monitoring. 
Previous cases of patients with tufted angioma 
presenting with chronic coagulopathy in the 
absence of thrombocytopenia have been reported 
[6]. This suggests that coagulopathy may be more 
prevalent among patients with tufted angioma than 
the rates of Kasabach-Merritt phenomenon would 
suggest. These findings also suggest that 
coagulopathies may present in these patients to 
varying degrees and supports the need to obtain 
baseline laboratory workup in patients presenting 
with tufted angioma or kaposiform 
hemangioendothelioma. 
 
Conclusion 
This is a case of tufted angioma in an asymptomatic 
patient who was found to have a mild coagulopathy 
on laboratory workup. 
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Figure 2. A) Punch biopsy of right medial arm demonstrating 
vascular proliferation in the superficial dermis mimicking “tufts.” 
H&E, 100×. B) ERG immunohistochemical staining demonstrating 
vascular nature of the lesion, 60×. 
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